References
- MassarwehNNEl-SeragHBEpidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinomaCancer Control2017243 1073274817729245
- IoannouGNGreenPKBerryKHCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinomaJ Hepatol Epub201795
- RyersonABEhemanCRAltekruseSFAnnual Report to the Nation on the Status of Cancer, 1975–2012, featuring the increasing incidence of liver cancerCancer201612291312133726959385
- TorresHAShigleTLHammoudiNThe oncologic burden of hepatitis C virus infection: a clinical perspectiveCA Cancer J Clin201767541143128683174
- TorresHAMahalePBlechaczBEffect of hepatitis C virus infection in patients with cancer: addressing a neglected populationJ Natl Compr Canc Netw2015131415025583768
- MahalePKasebAOHassanMMTorresHAHepatocellular carcinoma as a second primary cancer in patients with chronic hepatitis C virus infectionDig Liver Dis201547434834925563811
- AngelidakisGHwangJPDandachiDUniversal screening for hepatitis C: a needed approach in patients with hematologic malignanciesJ Viral Hepat Epub2018416
- TorresHAHosryJMahalePEconomidesMPJiangYLokASHepatitis C virus reactivation in patients receiving cancer treatment: a prospective observational studyHepatology2018671364728653760